Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.

In a prospective study conducted in a diagnostic laboratory in Mexico City, luciferase reporter mycobacteriophages (LRPs) were evaluated for their utility and performance in identification and antibiotic-susceptibility testing of Mycobacterium tuberculosis complex (MTC) isolates from MGIT-960 cultures. Eighty-four consecutive MGIT cultures recovered from 54 patients were included in this study. The LRPs confirmed mycobacterial growth in 79 (94 %) of 84 MGIT cultures. Failure to confirm growth was due to low inoculum (n = 1) or growth with non-tuberculous mycobacteria (n = 4). The median time to confirmation of MGIT cultures was 1 day (range 1-55). Confirmed cultures were identified with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone (NAP), a selective inhibitor of MTC species, and results obtained with LRPs were compared with those obtained by BACTEC-460. The sensitivity and specificity of the LRP NAP test were respectively 97 and 100 %, and the median turnaround time for identification was 3 days with both methods. The accuracy and speed of the LRPs for susceptibility testing with rifampicin, streptomycin, isoniazid and ethambutol were compared with BACTEC-460 and discrepant results were tested by the conventional agar proportion method. In total, 72 MTC cultures were tested. The overall agreement between the LRPs and BACTEC-460 was 98.6 %. Four isolates (5.6 %) were falsely identified as ethambutol-resistant. The median turnaround time for susceptibility testing was 3 days (range 3-57) with the LRPs and 9 days (range 7-29) with BACTEC-460. LRPs offer an accurate and rapid approach for identification and susceptibility testing of M. tuberculosis from MGIT-960 cultures.

[1]  John Chan,et al.  Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system. , 2003, Diagnostic microbiology and infectious disease.

[2]  W. Jacobs,et al.  Luciferase Reporter Mycobacteriophages for Detection, Identification, and Antibiotic Susceptibility Testing ofMycobacterium tuberculosis in Mexico , 2001, Journal of Clinical Microbiology.

[3]  M. Espinal,et al.  Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  A. Khomenko,et al.  Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. , 2000, JAMA.

[5]  M. Pagano,et al.  Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  G. Cangelosi,et al.  Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[7]  M. Gismondo,et al.  Multicenter Evaluation of the Mycobacteria Growth Indicator Tube for Testing Susceptibility of Mycobacterium tuberculosis to First-Line Drugs , 1999, Journal of Clinical Microbiology.

[8]  T. Joint Chemotherapy and management of tuberculosis in the United Kingdom : recommendations 1998 Joint Tuberculosis , 1998 .

[9]  W. Jacobs,et al.  Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone , 1997, Journal of clinical microbiology.

[10]  D. Alland,et al.  Improved outcomes for patients with multidrug-resistant tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  G. Sarkis,et al.  Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. , 1993, Science.

[12]  J. T. Crawford,et al.  The resurgence of tuberculosis: is your laboratory ready? , 1993, Journal of clinical microbiology.

[13]  W. Gross,et al.  Radiometric selective inhibition tests for differentiation of Mycobacterium tuberculosis, Mycobacterium bovis, and other mycobacteria , 1985, Journal of clinical microbiology.

[14]  T. Timme,et al.  Induction of bacteriophage from members of the Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium scrofulaceum serocomplex. , 1984, Journal of general microbiology.

[15]  S. Siddiqi,et al.  Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone , 1984, Journal of clinical microbiology.